Bill
SB 2733
Overview: SB 2733, "NPLEx; require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of", died in committee. It was introduce
Overview: SB 2733, "NPLEx; require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of", died in committee. It was introduced on March 13, 2025.
Purpose and Intent: The bill aimed to require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of the National Precursor Log Exchange (NPLEx) system. The NPLEx system is used to track the sale of these products, which can be used to manufacture methamphetamine.
Key Provisions:
- Manufacturers of pseudoephedrine or ephedrine products would be required to pay fees to support the administration of the NPLEx system.
- The fees would be used to cover the costs of operating and maintaining the NPLEx system.
Affected Parties and Impacts:
- Manufacturers of pseudoephedrine or ephedrine products would be required to pay the fees, which could increase their costs.
- The NPLEx system would continue to be supported, which could help prevent the diversion of these products for the manufacture of methamphetamine.
Procedural and Timeline Considerations:
The bill died in committee and did not advance further in the legislative process.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
